Biotechnology company Verenium Corp. (VRNM) said Monday it has repurchased all its outstanding 5.5 percent convertible senior notes due 2027.
The tender offer period for the put option on the notes expired on March 30
All noteholders validly tendered their notes and the company repurchased the outstanding principal amount of $34.9 million.
Verenium paid $35.8 million in cash to its noteholders, including accrued and unpaid interest, for completing this repurchase.
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org